Dramatic change in the properties of magnetite-modified MOF particles depending on the synthesis approach
Lyubov Bondarenko,
Rose Baimuratova,
Marco Reindl,
Verena Zach,
Artur Dzeranov,
Denis Pankratov,
Kamila Kydralieva,
Gulzhian Dzhardimalieva,
Dagmar Kolb,
Friedrich E. Wagner,
Sebastian P. Schwaminger
Affiliations
Lyubov Bondarenko
Moscow Aviation Institute (National Research University), Moscow, 125993, Russia
Rose Baimuratova
Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, 119991, Russia
Marco Reindl
Division of Medicinal Chemistry, Otto-Loewi Research Center, Medical University of Graz, 8010 Graz, Austria
Verena Zach
Division of Medicinal Chemistry, Otto-Loewi Research Center, Medical University of Graz, 8010 Graz, Austria
Artur Dzeranov
Moscow Aviation Institute (National Research University), Moscow, 125993, Russia; Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, 119991, Russia
Denis Pankratov
Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia
Kamila Kydralieva
Moscow Aviation Institute (National Research University), Moscow, 125993, Russia
Gulzhian Dzhardimalieva
Moscow Aviation Institute (National Research University), Moscow, 125993, Russia; Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, 119991, Russia
Dagmar Kolb
Core Facility Ultrastructure Analysis, Center for Medical Research, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria; Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria; BioTechMed-Graz, 8010 Graz, Austria
Friedrich E. Wagner
Department of Physics, Technical University of Munich, James-Franck-Straße 1, 85748 Garching, Germany
Sebastian P. Schwaminger
Division of Medicinal Chemistry, Otto-Loewi Research Center, Medical University of Graz, 8010 Graz, Austria; BioTechMed-Graz, 8010 Graz, Austria; Corresponding author. Division of Medicinal Chemistry, Otto-Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Iron-containing metal–organic frameworks are promising Fenton catalysts. However, the absence of additional modifiers has proven difficult due to the low reaction rates and the inability to manipulate the catalysts. We hypothesize that the production of iron oxide NPs in the presence of a metal-organic framework will increase the rate of the Fenton reaction and lead to the production of particles that can be magnetically manipulated without changing the structure of the components. A comprehensive approach lead to a metal organic framework using the example of MIL-88b (Materials of Institute Lavoisier) modified with iron oxides NPs: formulation of iron oxide in the presence of MIL-88b and vice versa. The synthesis of MIL-88b consists of preparing a complexation compound with the respective structure and addition of terephthalic acid. The synthesis of MIL-88b facilitates to control the topology of the resulting material. Both methods for composite formulation lead to the preservation of the structure of iron oxide, however, a more technologically complex approach to obtaining MIL-88b in the presence of Fe3O4 suddenly turned out to be the more efficient for the release of iron ions.